Viewing Study NCT05514132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:31 PM
Ignite Modification Date: 2026-03-28 @ 8:22 AM
Study NCT ID: NCT05514132
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-10
First Post: 2022-08-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumours View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None Safety View
None Tolerability View
None Pharmacokinetics View
None Advanced solid tumours View